The Expression and Clinical Value of MMP-2 and MMP-9 in Hepatocellular Carcinoma

ZHONG Chong,SU Xiaokang,WEI Wei,LI Huidong,GUO Rongping

DOI: https://doi.org/10.3969/j.issn.1674-4659.2010.10.004

2010-01-01

Abstract:Objective The reports on the value of MMP-2/9 in estimating the prognosis of HCC patients are controversial. This study is to investigate the expression and clinical value of MMP-2/9 in estimating the invasion and prognosis of HCC. Methods The expression of MMP-2/9 in 64 serum and resection specimens of HCC was detected by enzyme-linked immunosorbent assay(ELISA) and immunohistoche-mistry. Of the 64 patients,42 had tumor recurred after operation. Correlations of the expression of MMP-2/9 to clinicopathologic features were analyzed. Results The serum level of MMP-2/9 was significantly higher in recurrent group than in non-recurrent group(P <0.05) ,respectively. MMP-2/9 was expressed in cytoplasm,respectively. The positive rate of MMP-2/9 was significantly higher in recurrent group than in non-recurrent group(73.8% vs. 40.9%,59.5% vs. 18.2%,P <0.05) ,respectively. The 1-,2-,and 3-year tumor-freely survival rates were significantly higher in MMP-2(-) group than in MMP-2(+) group(76.0% vs. 48.7%,60.0% vs. 30.8%,56.0% vs. 25.6%,P <0.01) ,and were significantly higher in MMP-9(-) group than in MMP-9(+) group(77.1% vs. 37.9%,65.8% vs. 13.8%,and 57.1% vs. 13.8%,P <0.01) . Multivariate analysis revealed that preoperative disseminated nodes,tumor micrometastasis,and the expression of MMP-2/9 were independent recurrence risk factors. Conclusion The expression of MMP-2/9 in serum and specimens of HCC patients ascends distinctly,which correlates to the recurrence of HCC after hepatectomy.